Detail of "37257-11-7"
- CAS Number:
- 37257-11-7
- Name:
E.C. 2.3.1.29
E.C. 2.3.1.29
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Gene expression profiling of colon cancer by microarray hybridization and correlation with survival and histoclinical parameters
- Gene expression profiling of colon cancer by microarray hybridization and correlation with survival and histoclinical parameters. Bertucci, Francois; Houlgatte, Remi; Birnbaum, Daniel; Debono, Stephane (Ipsogen; Institut, Paoli-Calmettes Ipc; Institut National de la Sante Et de la Recherche Medicale Inserm, Fr.). PCT Int. Appl. WO 2005054508 A2 16 Jun 2005, 154 pp. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IS, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. 37257-11-7 is the cas registry number. This chemical is also mentioned in this article. (English). (World Intellectual Property Organization). CODEN: PIXXD2. CLASS: ICM: C12Q001-68. APPLICATION: WO 2004-IB4323 1 Dec 2004. PRIORITY: US 2003-2003/PV52598U 1 Dec 2003; US 2004-2004/688 1 Dec 2004. DOCUMENT TYPE: Patent CA Section: 14 (Mammalian Pathological Biochemistry) Section cross-reference(s): 3 Genes showing altered levels of expression in neoplastic colon tissue compared to healthy colon tissue are identified for use in diagnosis and prognosis of colorectal carcinomas. Expression data are integrated with information from clin. examn. to select therapies and to prognosticate the chances of survival. .

